Drug Enforcement Administration 2017 – Federal Register Recent Federal Regulation Documents

Results 151 - 165 of 165
Importer of Controlled Substances Application: Hospira
Document Number: 2017-03273
Type: Notice
Date: 2017-02-21
Agency: Drug Enforcement Administration, Department of Justice
Frank D. Li, M.D.; Decision and Order
Document Number: 2017-03272
Type: Notice
Date: 2017-02-21
Agency: Drug Enforcement Administration, Department of Justice
Paul E. Pilgram, M.D.; Decision and Order
Document Number: 2017-03223
Type: Notice
Date: 2017-02-17
Agency: Drug Enforcement Administration, Department of Justice
Lee B. Drake, M.D. Decision and Order
Document Number: 2017-03222
Type: Notice
Date: 2017-02-17
Agency: Drug Enforcement Administration, Department of Justice
John P. Moore, III, M.D.; Decision and Order
Document Number: 2017-02729
Type: Notice
Date: 2017-02-10
Agency: Drug Enforcement Administration, Department of Justice
Janet Carol Dean, M.D.; Decision and Order
Document Number: 2017-02321
Type: Notice
Date: 2017-02-03
Agency: Drug Enforcement Administration, Department of Justice
Richard W. Walker, Jr., M.D.; Decision and Order
Document Number: 2017-02320
Type: Notice
Date: 2017-02-03
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Extension of Temporary Placement of THJ-2201, AB-PINACA and AB-CHMINACA in Schedule I of the Controlled Substances Act
Document Number: 2017-01517
Type: Rule
Date: 2017-01-27
Agency: Drug Enforcement Administration, Department of Justice
The Administrator of the Drug Enforcement Administration is issuing this temporary order to extend the temporary schedule I status of three synthetic cannabinoids pursuant to the temporary scheduling provisions of the Controlled Substances Act. The substances are: [1-(5- Fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (THJ-2201); N- 1-Amino-3-methyl-1-oxo-2-butanyl]-1-pentyl-1H-indazole-3-carb oxamide (AB-PINACA); N-[1-Amino-3-methyl-1-oxo-2-butanyl]-1-(cyclohexylmethyl)- 1H-indazole-3-carboxamide (AB-CHMINACA), including their optical, positional and geometric isomers, salts, and salts of isomers. The current final order temporarily placing THJ-2201, AB-PINACA and AB- CHMINACA into schedule I is in effect through January 29, 2017. This order will extend the temporary scheduling of THJ-2201, AB-PINACA and AB-CHMINACA for one year, or until the permanent scheduling action for these three substances is completed, whichever occurs first.
Schedules of Controlled Substances: Placement of AB-CHMINACA, AB-PINACA and THJ-2201 Into Schedule I
Document Number: 2017-01514
Type: Proposed Rule
Date: 2017-01-27
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration proposes placing N-(1- amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indaz ole-3- carboxamide (AB-CHMINACA), N-(1-amino-3-methyl-1-oxobutan-2-yl)-1- pentyl-1H-indazole-3-carboxamide (AB-PINACA) and [1-(5-fluoropentyl)- 1H-indazol-3-yl](naphthalen-1-yl)methanone (THJ-2201), including their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, into schedule I of the Controlled Substances Act. This proposed scheduling action is pursuant to the Controlled Substances Act which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking. If finalized, this action would continue to impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle AB-CHMINACA, AB-PINACA and THJ-2201.
Gentry Reeves Dunlop, M.D.; Decision and Order
Document Number: 2017-01690
Type: Notice
Date: 2017-01-25
Agency: Drug Enforcement Administration, Department of Justice
Donald W. Lamoureaux, M.D.; Decision and Order
Document Number: 2017-01688
Type: Notice
Date: 2017-01-25
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Organix, Inc.
Document Number: 2017-01582
Type: Notice
Date: 2017-01-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Mylan Technologies, Inc.
Document Number: 2017-01305
Type: Notice
Date: 2017-01-23
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) Into Schedule I
Document Number: 2017-00275
Type: Proposed Rule
Date: 2017-01-09
Agency: Drug Enforcement Administration, Department of Justice
The Administrator of the Drug Enforcement Administration is issuing this notice of intent to temporarily schedule six synthetic cannabinoids: Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)- 3,3-dimethylbutanoate [5F-ADB; 5F-MDMB-PINACA]; methyl 2-(1-(5- fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate [5F-AMB]; N- (adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide [5F- APINACA, 5F-AKB48]; N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4- fluorobenzyl)-1H-indazole-3-carboxamide [ADB-FUBINACA]; methyl 2-(1- (cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutan oate [MDMB-CHMICA, MMB-CHMINACA] and methyl 2-(1-(4-fluorobenzyl)-1H- indazole-3-carboxamido)-3,3-dimethylbutanoate [MDMB-FUBINACA], into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act (CSA). This action is based on a finding by the Administrator that the placement of these synthetic cannabinoids into schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. Any final order will impose the administrative, civil, and criminal sanctions and regulatory controls applicable to schedule I substances under the Controlled Substances Act on the manufacture, distribution, possession, importation, exportation of, and research and conduct with, instructional activities of these synthetic cannabinoids.